Search Results - "ROSSOL, S"

P0817 : Cost-effectiveness of treating chronic hepatitis C genotype-1 with ledipasvir and sofosbuvir in Germany by Stahmeyer, J.T, Rossol, S, Bert, F, Guerra, I.M, Krauth, C

Get full text

Costs of a guideline-based treatment of patients with chronic hepatitis C in the era of interferon-free treatment by Stahmeyer, J T, Rossol, S, Bert, F, Liersch, S, Krauth, C

“…The treatment of chronic hepatitis C has considerably changed with the introduction of recent direct acting antivirals. These antivirals have sustained…”
Get more information

Costs and outcomes of treating chronic hepatitis C patients in routine care - results from a nationwide multicenter trial by Stahmeyer, J. T., Krauth, C., Bert, F., Pfeiffer-Vornkahl, H., Alshuth, U., Hüppe, D., Mauss, S., Rossol, S.

“…Summary Viral hepatitis is a major public health problem affecting millions of people worldwide. Long‐term consequences are the development of liver cirrhosis…”
Get full text

A randomized, double‐blind study of certoparin vs. unfractionated heparin to prevent venous thromboembolic events in acutely ill, non‐surgical patients: CERTIFY Study by RIESS, H., HAAS, S., TEBBE, U., GERLACH, H.‐E., ABLETSHAUSER, C., SIEDER, C., ROSSOL, S., PFEIFFER, B., SCHELLONG, S. M.

“…Background: In medically ill patients, no contemporary double‐blind head‐to‐head evaluation of low molecular weight heparin vs. unfractionated heparin (UFH)…”
Get full text

Usefullness of ARFI for the Detection of Liver Damage in Routine Ultrasound by Bert, F, Rossol, S

Get full text

Inflammatory cytokines in subarachnoid haemorrhage: association with abnormal blood flow velocities in basal cerebral arteries by Fassbender, K, Hodapp, B, Rossol, S, Bertsch, T, Schmeck, J, Schütt, S, Fritzinger, M, Horn, P, Vajkoczy, P, Kreisel, S, Brunner, J, Schmiedek, P, Hennerici, M

“…Subarachnoidal release of inflammatory cytokines (interleukin (IL)-1β, IL-6, and tumour necrosis factor (TNF)-α) was characterised in 35 patients with…”
Get full text

Chronic HCV infections. A model disease for therapy, economics and social-medical aspects by Rossol, S

“…In Germany up to 800,000 persons are chronically infected with the hepatis C virus. This chronic disease is correlated with a significant morbidity and…”
Get more information

Costs of a guideline-based treatment of patients with chronic hepatitis C in Germany by Stahmeyer, J T, Rossol, S, Bert, F, Abdelfattah, M, Krauth, C

“…The costs of a guideline-based treatment in chronic hepatitis C infected people are unknown. The goal of HCV therapy is to achieve a sustained viral response…”
Get more information

P1147 OUTCOMES AND COSTS OF TREATING HEPATITIS C WITH PROTEASE INHIBITORS: RESULTS FROM A MULTI-CENTRE STUDY by Stahmeyer, J.T, Rossol, S, Bert, F, Abdelfattah, A.M, Mauss, S, Heyne, R, John, C, Pape, S, Schober, A, Teuber, G, Bruch, H.R, Zehnter, E, Hueppe, D, Pfeiffer-Vornkahl, H, Alshuth, U, Krauth, C

Get full text

Cost of illness of hepatitis c in germany: A retrospective multicenter analysis by Stahmeyer, J.T, Rossol, S, Bert, F, Abdelfattah, M, Wiebner, B, Wedemeyer, H, Krauth, C

Get full text

Butyrate modulates intestinal epithelial cell‐mediated neutrophil migration by BÖCKER, U., NEBE, T., HERWECK, F., HOLT, L., PANJA, A., JOBIN, C., ROSSOL, S., B. SARTOR, R., SINGER, M. V.

“…SUMMARY Butyrate, a short‐chain fatty acid released by colonic bacteria and administered therapeutically in inflammatory bowel diseases, exerts…”
Get full text

797 HIGH PREVALENCE OF CHRONIC HEPATITIS C IN 8009 PATIENTS WITH MIGRATION BACKGROUND LIVING IN GERMANY by Buggisch, P, Petersen, J, Urlea-Schön, I, Rossol, S, Möller, B, Heyne, R, Weissmann, J, Malek, M, Teuber, G, John, C, Hey, K.-H, Melcher, L, Witth öft, T, Blaak, H, Hartmann, D, Bilzer, M

Get full text

PIN38 Guideline Evaluation of Costs Related to Chronic Hepatitis C and Antiviral Treatment Strategies by Stahmeyer, J.T, Krauth, C, Abdelfattah, M, Bert, F, Rossol, S

Get full text

Epidemiology, Treatment Outcomes and Costs of Treating Hepatitis C in Routine Care – Results from a Large Multicenter Trial by Stahmeyer, J.T, Rossol, S, Bert, F, Abdelfattah, A.M, Mauss, S, Heyne, R, John, C, Pape, S, Schober, A, Teuber, G, Bruch, H.R, Zehnter, E, Hueppe, D, Pfeiffer-Vornkahl, H, Alshuth, U, Krauth, C

Get full text

Interleukin-12 induction of Th1 cytokines is important for viral clearance in chronic hepatitis B by Rossol, S, Marinos, G, Carucci, P, Singer, M V, Williams, R, Naoumov, N V

“…Interleukin-12, a cytokine with an important role against intracellular pathogens, promotes Th1 cell development, cellmediated cytotoxicity, and…”
Get full text

Interferon-γ-inducing factor (IL-18) and interferon-γ in inflammatory CNS diseases by FASSBENDER, K, MIELKE, O, BERTSCH, T, MUEHLHAUSER, F, HENNERICI, M, KURIMOTO, M, ROSSOL, S

“…To examine the intrathecal production of a newly identified cytokine, interferon-gamma-inducing factor (IL-18), together with interferon-gamma itself, in…”
Get full text

Hepatitis C virus (HCV) specific immune responses in anti-HCV positive patients without hepatitis C viraemia by Cramp, M E, Carucci, P, Rossol, S, Chokshi, S, Maertens, G, Williams, R, Naoumov, N V

“…BACKGROUND/AIMS Most patients infected with hepatitis C virus (HCV) develop chronic infection and persistent viraemia. The immune mechanisms responsible for…”
Get full text

Increased release of interleukin-12p40 in MS : Association with intracerebral inflammation by FASSBENDER, K, RAGOSCHKE, A, ROSSOL, S, SCHWARTZ, A, MIELKE, O, PAULIG, A, HENNERICI, M

“…The p40 subunit of interleukin (IL)-12 was recently demonstrated in active lesions in MS. We tested whether the p40 subunit of IL-12 can also be detected in…”
Get full text

Kinetics of soluble tumour necrosis factor (TNF)‐α receptors and cytokines in the early phase of treatment for chronic hepatitis C: comparison between interferon (IFN)‐α alone, IFN‐α plus amantadine or plus ribavirin by TORRE, F., ROSSOL, S., PELLI, N., BASSO, M., DELFINO, A., PICCIOTTO, A.

“…SUMMARY We have previously studied the effect of three different treatment regimens with interferon (IFN)‐α alone or in combination with amantadine or…”
Get full text

Induction of tumour necrosis factor (TNF) receptor type p55 and p75 in patients with chronic hepatitis C virus (HCV) infection by KALLINOWSKI, B, HASEROTH, K, MARINOS, G, HANCK, C, STREMMEL, W, THEILMANN, L, SINGER, M. V, ROSSOL, S

“…There is evidence that TNF‐α contributes to the pathogenesis of chronic viral hepatitis. The cellular effects of this cytokine are regulated by two specific…”
Get full text